Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Louise Duus Holle

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
JACC. Case Reports|June 6, 2025
Unexpected Percutaneous Ventricular Assist Device Failure in a Complex Case of Infarct-Related Cardiogenic ShockSarah Louise Duus Holle, Jacob Eifer Møller, Hans-Henrik Tilsted, et al.
Cardiology|May 18, 2026
A Risk Score Without a Window: The Clinical Timing Problem of ORBI (Observatoire Régional Breton sur l'Infarctus) Risk ScoreSarah Louise Duus Holle, Helle Søholm, Martin Frydland, et al.
American Heart Journal|April 7, 2025
Infective endocarditis and the association to income as a proxy for socioeconomic position: A Danish nationwide register-based cohort studyKasper Høtoft Bengtsen, Charlotte Helene Wichmand, Sarah Louise Duus Holle, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 8, 2025
The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarctionSarah Louise Duus Holle, Helle Søholm, Jacob Eifer Møller, et al.
Resuscitation|April 12, 2026
Effect of Vascular Access Strategy on Long-Term Outcomes in Patients with Out-of-hospital Cardiac Arrest A Randomised Clinical TrialMikael Fink Vallentin, Mathias J Holmberg, Asger Granfeldt, et al.
Resuscitation|May 10, 2025
Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trialMikael Fink Vallentin, Mathias J Holmberg, Asger Granfeldt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
JACC. Case Reports|June 6, 2025
Unexpected Percutaneous Ventricular Assist Device Failure in a Complex Case of Infarct-Related Cardiogenic ShockSarah Louise Duus Holle, Jacob Eifer Møller, Hans-Henrik Tilsted, et al.
Cardiology|May 18, 2026
A Risk Score Without a Window: The Clinical Timing Problem of ORBI (Observatoire Régional Breton sur l'Infarctus) Risk ScoreSarah Louise Duus Holle, Helle Søholm, Martin Frydland, et al.
American Heart Journal|April 7, 2025
Infective endocarditis and the association to income as a proxy for socioeconomic position: A Danish nationwide register-based cohort studyKasper Høtoft Bengtsen, Charlotte Helene Wichmand, Sarah Louise Duus Holle, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 8, 2025
The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarctionSarah Louise Duus Holle, Helle Søholm, Jacob Eifer Møller, et al.
Resuscitation|April 12, 2026
Effect of Vascular Access Strategy on Long-Term Outcomes in Patients with Out-of-hospital Cardiac Arrest A Randomised Clinical TrialMikael Fink Vallentin, Mathias J Holmberg, Asger Granfeldt, et al.
Resuscitation|May 10, 2025
Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trialMikael Fink Vallentin, Mathias J Holmberg, Asger Granfeldt, et al.
Pageof 1